Literature DB >> 11922607

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.

Haleem J Issaq1, Timothy D Veenstra, Thomas P Conrads, Donna Felschow.   

Abstract

The need for methods to identify disease biomarkers is underscored by the survival-rate of patients diagnosed at early stages of cancer progression. Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) is a novel approach to biomarker discovery that combines two powerful techniques: chromatography and mass spectrometry. One of the key features of SELDI-TOF MS is its ability to provide a rapid protein expression profile from a variety of biological and clinical samples. It has been used for biomarker identification as well as the study of protein-protein, and protein-DNA interaction. The versatility of SELDI-TOF MS has allowed its use in projects ranging from the identification of potential diagnostic markers for prostate, bladder, breast, and ovarian cancers and Alzheimer's disease, to the study of biomolecular interactions and the characterization of posttranslational modifications. In this minireview we discuss the application of SELDI-TOF MS to protein biomarker discovery and profiling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922607     DOI: 10.1006/bbrc.2002.6678

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  98 in total

1.  Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.

Authors:  Naoki Fujita; Mamoru Nakanishi; Jun Mukai; Yuuji Naito; Takafumi Ichida; Masahiko Kaito; Toshikazu Yoshikawa; Yoshiyuki Takei
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 2.  Clinical applications of proteomics: proteomic pattern diagnostics.

Authors:  Emanuel E Petricoin; Cloud P Paweletz; Lance A Liotta
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

Review 3.  Functional genomics and proteomics: application in neurosciences.

Authors:  K E Wilson; M M Ryan; J E Prime; D P Pashby; P R Orange; G O'Beirne; J G Whateley; S Bahn; C M Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

4.  Apoptosis in cancer: archaeology, functional relevance and exploitation in novel treatment strategies.

Authors:  E F Gaffney
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

5.  Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.

Authors:  Georges J Netto; Rana Saad
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-01

Review 6.  Teaching molecular genetics: Chapter 3--Proteomics in nephrology.

Authors:  Patricia J T A Groenen; Lambert P W J van den Heuvel
Journal:  Pediatr Nephrol       Date:  2006-03-30       Impact factor: 3.714

Review 7.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 8.  Proteomics in cancer screening and management in gynecologic cancer.

Authors:  Wei Hu; Weiguo Wu; Ryuji Kobayashi; John J Kavanagh
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 9.  Moving forward in colorectal cancer research, what proteomics has to tell.

Authors:  Nerea Bitarte; Eva Bandrés; Ruth Zárate; Natalia Ramirez; Jesus Garcia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

10.  The knowledge-integrated network biomarkers discovery for major adverse cardiac events.

Authors:  Guangxu Jin; Xiaobo Zhou; Honghui Wang; Hong Zhao; Kemi Cui; Xiang-Sun Zhang; Luonan Chen; Stanley L Hazen; King Li; Stephen T C Wong
Journal:  J Proteome Res       Date:  2008-07-30       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.